MAZE logo

Maze Therapeutics, Inc. (MAZE)

Profile

Full Name

Maze Therapeutics, Inc.

Ticker

NASDAQ: MAZE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 31, 2025

Indexes

Not included

Website

https://www.mazetx.com

Employees

125

Key Details

Price

$23.30(-6.07%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$167.50M(+100.00% YoY)

Annual EPS

$0.00(0.00% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $23.30
    MAZE price is $23.30

    30-Day Relative Volume

    2.55
    MAZE 30-day relative volume is 2.55

    Price Performance

    Price Most recent change

    -6.07%
    MAZE price was down -6.07% on Sep 12, 2025

    Price YTD change

    -
    MAZE price ytd change is unknown

    Price 1-year change

    -
    MAZE price 1-year change is unknown

    Price 3-year change

    -
    MAZE price 3-year change is unknown

    Price Range

    Price All-time high

    $25.50
    MAZE price is currently -8.65% below its historical high of $25.50

    Price 3-year low

    $6.71
    MAZE price is currently +247.17% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.02B
    MAZE market capitalization is $1.02 billion

    Market cap 3-year change

    -
    MAZE market capitalization 3-year change is unknown

    Market cap All-time high

    $1.09B
    MAZE market capitalization is currently -6.07% below its historical high of $1.09 billion

    Market cap sector rank

    72.58%
    MAZE market capitalization is higher than 72.58% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.17%
    MAZE shares outstanding is up +0.17% year-on-year

    Shares Outstanding 3-Year Change

    -
    MAZE shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.89
    MAZE beta is 0.89

    200-day SMA

    $12.41
    MAZE price is currently +87.75% above its 200-day simple moving average

    50-day SMA

    $15.22
    MAZE price is currently +53.05% above its 50-day simple moving average

    RSI

    75.53
    MAZE 14-day relative strength index is 75.53

    Volume

    2.55
    MAZE 30-day relative volume is 2.55

    ATR

    $2.00
    MAZE average true range is $2.00

    10-day Historical Volatility

    282.72%
    MAZE 10-day historical volatility is 282.72%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $167.50M
    MAZE annual revenue is $167.50 million

    Revenue Analysts estimate

    -
    MAZE annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +100%
    MAZE annual revenue is up +100% year-on-year

    Revenue Sector rank

    72.25%
    MAZE annual revenue is higher than 72.25% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    MAZE annual earnings per share is $0.00

    EPS Analysts estimate

    -$3.17
    MAZE annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    MAZE annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    82.41%
    MAZE annual earnings per share is higher than 82.41% of companies in Healthcare sector

    Profit

    Gross profit

    $164.20M
    MAZE annual gross profit is $164.20 million

    Gross margin

    98.03%
    MAZE annual gross profit margin is 98.03%

    Operating profit

    $57.59M
    MAZE annual operating income is $57.59 million

    Operating margin

    34.38%
    MAZE annual operating profit margin is 34.38%

    Net income

    $18.38M
    MAZE annual net profit is $18.38 million

    Net margin

    10.97%
    MAZE annual net profit margin is 10.97%

    Expenses

    Total expenses

    $109.91M
    MAZE annual total expenses is $109.91 million

    Operating expenses

    $109.91M
    MAZE annual total operating expenses is $109.91 million

    Cost of goods sold

    $3.30M
    MAZE annual cost of goods sold is $3.30 million

    Selling, general & administrative expenses

    $26.42M
    MAZE annual SGA is $26.42 million

    Depreciation and amortization

    $3.30M
    MAZE annual depreciation & amortization is $3.30 million

    Interest expense

    $0.00
    MAZE annual interest expense is $0.00

    Income tax

    $1.17M
    MAZE annual income tax is $1.17 million

    EBIT & EBITDA

    EBIT

    $57.59M
    MAZE annual earnings before interest & taxes is $57.59 million

    EBITDA

    $60.88M
    MAZE annual EBITDA is $60.88 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $240.54M
    MAZE annual total assets is $240.54 million

    Non current assets

    $38.87M
    MAZE annual long term assets is $38.87 million

    Current assets

    $201.67M
    MAZE annual total current assets is $201.67 million

    Cash and cash equivalents

    $196.81M
    MAZE annual cash & cash equivalents is $196.81 million

    Accounts receivable

    -
    MAZE annual accounts receivable value is unknown

    Inventory

    $0.00
    MAZE annual inventory is $0.00

    Liabilities

    Total liabilities

    $43.64M
    MAZE annual total liabilities is $43.64 million

    Long term liabilities

    $531.05M
    MAZE annual total long term liabilities is $531.05 million

    Current liabilities

    $20.67M
    MAZE annual total current liabilities is $20.67 million

    Accounts payable

    $1.94M
    MAZE annual accounts payable is $1.94 million

    Debt

    Total debt

    $26.63M
    MAZE annual total debt is $26.63 million

    Total debt 1-year change

    -46.34%
    MAZE annual total debt is down -46.34% year-on-year

    Long term debt

    $22.00M
    MAZE annual long term debt is $22.00 million

    Short term debt

    $4.63M
    MAZE annual short term debt is $4.63 million

    Equity & Capital

    Shareholders equity

    $196.90M
    MAZE annual stockholders equity is $196.90 million

    Book value

    -$311.18M
    MAZE annual book value is -$311.18 million

    Retained earnings

    -$358.43M
    MAZE annual retained earnings is -$358.43 million

    Working capital

    $181.00M
    MAZE annual working capital is $181.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $75.95M
    MAZE annual cash flow from operations is $75.95 million

    Cash from operations 1-year change

    +187.48%
    MAZE annual cash flow from operations is up +187.48% year-on-year

    Cash from investing

    -$1.15M
    MAZE annual cash flow from investing activities is -$1.15 million

    Cash from investing 1-year change

    -160.09%
    MAZE annual cash flow from investing activities is down -160.09% year-on-year

    Cash from financing

    $92.85M
    MAZE annual cash flow from financing activities is $92.85 million

    Cash from financing 1-year change

    +466.66%
    MAZE annual cash flow from financing activities is up +466.66% year-on-year

    CAPEX

    CAPEX

    $1.15M
    MAZE annual capital expenditures is $1.15 million

    CAPEX 1-year change

    +160.09%
    MAZE annual capital expenditures is up +160.09% year-on-year

    Free Cash Flow

    Free cash flow

    $74.81M
    MAZE annual free cash flow is $74.81 million

    Free cash flow 1-year change

    +185.72%
    MAZE annual free cash flow is up +185.72% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    98.03%
    MAZE annual gross profit margin is 98.03%

    Operating margin

    34.38%
    MAZE annual operating profit margin is 34.38%

    Net margin

    10.97%
    MAZE annual net profit margin is 10.97%

    ROA & ROE

    ROA

    11.78%
    MAZE annual return on assets is 11.78%

    ROE

    17.76%
    MAZE annual return on equity is 17.76%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    MAZE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    MAZE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.90
    MAZE price to book ratio is 3.90

    PB ratio Sector rank

    72.01%
    MAZE price to book ratio is higher than 72.01% of companies in Healthcare sector

    PS Ratio

    PS ratio

    408.60
    MAZE price to sales ratio is 408.60

    PS ratio Sector rank

    95.42%
    MAZE price to sales ratio is higher than 95.42% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $781.97M
    MAZE enterprise value is $781.97 million

    Enterprise value Sector rank

    70.73%
    MAZE enterprise value is higher than 70.73% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -6.36
    MAZE EV/EBITDA is -6.36

    EV/EBITDA Sector rank

    19.34%
    MAZE EV/EBITDA is higher than 19.34% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    9.76
    MAZE annual current ratio is 9.76

    Quick ratio

    9.76
    MAZE annual quick ratio is 9.76

    Leverage

    Debt to equity

    0.14
    MAZE annual debt to equity ratio is 0.14

    Interest coverage ratio

    -
    MAZE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    MAZE piotroski f-score value is unknown

    Altman Z-Score

    14.35
    MAZE altman z-score is 14.35

    Analyst ratings

    Recent major analysts updates

    Sep 12, 25 HC Wainwright & Co.
    Buy
    Sep 12, 25 BTIG
    Buy
    Sep 11, 25 BTIG
    Buy
    Sep 2, 25 BTIG
    Buy
    Jul 23, 25 HC Wainwright & Co.
    Buy
    Jul 8, 25 Wedbush
    Outperform
    Apr 2, 25 Guggenheim
    Buy
    Feb 25, 25 Leerink Partners
    Outperform
    Feb 25, 25 JP Morgan
    Overweight
    Feb 25, 25 Guggenheim
    Buy

    Institutional Ownership

    Screeners with MAZE included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Maze Therapeutics, Inc.?
    • Does Maze Therapeutics, Inc. pay dividends?
    • What sector is Maze Therapeutics, Inc. in?
    • What industry is Maze Therapeutics, Inc. in?
    • What country is Maze Therapeutics, Inc. based in?
    • When did Maze Therapeutics, Inc. go public?
    • Is Maze Therapeutics, Inc. in the S&P 500?
    • Is Maze Therapeutics, Inc. in the NASDAQ 100?
    • Is Maze Therapeutics, Inc. in the Dow Jones?
    • When was Maze Therapeutics, Inc.'s last earnings report?
    • When does Maze Therapeutics, Inc. report earnings?

    What is the ticker symbol for Maze Therapeutics, Inc.?

    The ticker symbol for Maze Therapeutics, Inc. is NASDAQ:MAZE

    Does Maze Therapeutics, Inc. pay dividends?

    No, Maze Therapeutics, Inc. does not pay dividends

    What sector is Maze Therapeutics, Inc. in?

    Maze Therapeutics, Inc. is in the Healthcare sector

    What industry is Maze Therapeutics, Inc. in?

    Maze Therapeutics, Inc. is in the Biotechnology industry

    What country is Maze Therapeutics, Inc. based in?

    Maze Therapeutics, Inc. is headquartered in United States

    When did Maze Therapeutics, Inc. go public?

    Maze Therapeutics, Inc.'s initial public offering (IPO) was on January 31, 2025

    Is Maze Therapeutics, Inc. in the S&P 500?

    No, Maze Therapeutics, Inc. is not included in the S&P 500 index

    Is Maze Therapeutics, Inc. in the NASDAQ 100?

    No, Maze Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Maze Therapeutics, Inc. in the Dow Jones?

    No, Maze Therapeutics, Inc. is not included in the Dow Jones index

    When was Maze Therapeutics, Inc.'s last earnings report?

    Maze Therapeutics, Inc.'s most recent earnings report was on August 12, 2025

    When does Maze Therapeutics, Inc. report earnings?

    The next expected earnings date for Maze Therapeutics, Inc. is November 11, 2025
    On this page